Australien - engelska - Department of Health (Therapeutic Goods Administration)

amneal pharma australia pty ltd - hydrochlorothiazide,irbesartan -

Australien - engelska - Department of Health (Therapeutic Goods Administration)

amneal pharma australia pty ltd - hydrochlorothiazide,irbesartan -

Australien - engelska - Department of Health (Therapeutic Goods Administration)

dr falk pharma australia pty ltd - mesalazine, quantity: 2000 mg - enema - excipient ingredients: sodium benzoate; carbomer 934p; disodium edetate; potassium acetate; potassium metabisulfite; xanthan gum; purified water - salofalk enemas are indicated in the treatment of acute ulcerative colitis of mild to moderate severity and for the maintenance treatment of ulcerative colitis.

Australien - engelska - Department of Health (Therapeutic Goods Administration)

dr falk pharma australia pty ltd - mesalazine, quantity: 4000 mg - enema - excipient ingredients: sodium benzoate; carbomer 934p; disodium edetate; potassium acetate; potassium metabisulfite; xanthan gum; purified water - salofalk enemas are indicated in the treatment of acute ulcerative colitis of mild to moderate severity and for the maintenance treatment of ulcerative colitis.

Australien - engelska - Department of Health (Therapeutic Goods Administration)

dr falk pharma australia pty ltd - mesalazine, quantity: 2000 mg - enema - excipient ingredients: disodium edetate; potassium acetate; purified water; xanthan gum; potassium metabisulfite; carbomer 934p; sodium benzoate - salofalk enemas are indicated in the treatment of acute ulcerative colitis of mild to moderate severity and for the maintenance treatment of ulcerative colitis.

Australien - engelska - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - albendazole, quantity: 200 mg - tablet, chewable - excipient ingredients: maize starch; hypromellose; propylene glycol; sodium lauryl sulfate; lactose monohydrate; sodium starch glycollate; saccharin sodium; povidone; microcrystalline cellulose; magnesium stearate - single dose or short term courses of zentel are indicated in the treatment of single or mixed infestations of intestinal and tissue parasites, in adults and children over 2 years of age. clinical studies have shown zentel to be effective in the treatment of infections caused by: enterobius vermicularis (pinworm/threadworm), ascaris lumbricoides (roundworm), ancylostoma duodenale and necator americanus (hookworms), trichuris trichiura (whipworm), strongyloides stercoralis, animal hookworm lavae causing cutaneous lava migrans, and the liver flukes opisthorchis viverrini and clonorchis sinensis. zentel is also indicated for the treatment of hymenolepis nana and taenia spp. (tapeworm) infections, when other susceptible helminths species are present. treatment courses should be extended to 3 days. (see warnings and precautions)

Australien - engelska - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - albendazole, quantity: 200 mg - tablet, chewable - excipient ingredients: lactose monohydrate; maize starch; microcrystalline cellulose; sodium starch glycollate; povidone; magnesium stearate; sodium lauryl sulfate; saccharin sodium; hypromellose; propylene glycol - for single dose or short term courses indicated in the treatment of single or mixed infestations of intestinal and tissue parasites, in adults and children over 2 years of age. clinical studies have shown zentel to be effective in the treatment of infections caused by: enterobius vermicularis (pinworm/threadworm), ascaris lumbricoides (roundworm), ancylostoma duodenale and necator americanus (hookworms), trichuris trichiura (whipworm), strongyloides stercoralis, animal hookworm lavae causing cutaneous lava migrans, and the liver flukes opisthorchis viverrini and clonorchis sinensis. zentel is also indicated for the treatment of hymenolepis nana and taenia spp. (tapeworm) infections, when other susceptible helminths species are present. treatment courses should be extended to 3 days. (see warnings and precautions)

Australien - engelska - Department of Health (Therapeutic Goods Administration)

dr falk pharma australia pty ltd - mesalazine, quantity: 1 g - tablet, enteric coated - excipient ingredients: povidone; microcrystalline cellulose; croscarmellose sodium; colloidal anhydrous silica; calcium stearate; hypromellose; methacrylic acid copolymer; purified talc; titanium dioxide; iron oxide yellow; macrogol 6000 - salofalk tablets are indicated in the treatment of acute episodes and maintenance of remission of: i. mild to moderate ulcerative colitis; and ii. crohn?s ileitis and colitis

Australien - engelska - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - indometacin, quantity: 100 mg - suppository, moulded - excipient ingredients: macrogol 3350; purified water; glycerol; edetic acid; butylated hydroxyanisole; butylated hydroxytoluene; macrogol 8000 - indocid is indicated in active stage of: rheumatoid arthritis, osteoarthritis, degenerative joint disease of the hip, ankylosing spondylitis, gout. it is also indicated for: acute musculoskeletal disorders, such as bursitis, tendonitis, synovitis, tenosynovitis, tenosynovitis, capsulitis of the shoulder, sprains and strains; low back pain (commonly referred to as lumbago); inflammation, pain and oedema following orthopaedic surgical procedures and nonsurgical procedures associated with reduction and immobilisation of fractures or dislocations; pain and associated symptoms of primary dysmenorrhoea.

Australien - engelska - Department of Health (Therapeutic Goods Administration)

teva pharma australia pty ltd - donepezil hydrochloride -